BackTable Tumor Board

We just wrapped HCC Creator Weekend in New Orleans - and it did NOT disappoint! BackTable’s Hepatocellular Carcinoma (HCC) Creator Weekend brought together leading voices for exclusive in-studio sessions you’ll want to hear. All-new HCC episodes are on the way - and trust us, you won’t want to miss these. 🎙️ #Oncology #MedOnc #HCC #MultidisciplinaryCare #TumorBoard

That’s a wrap on HCC Creator Weekend in New Orleans! We sat down with leading experts from across the country to record new episodes on hepatocellular carcinoma management, emerging therapies, and multidisciplinary care. 🎙️ New episodes and bonus content will be dropping over the next several weeks in the BackTable app: na2.hubs.ly/H04hpTL0 Stay tuned. #HCC #LiverCancer #Oncology #TumorBoard #MedOnc #BackTable

@CedarsSinai oncologists Karen Reckamp and Jun Gong recently sat down with host Venkatesh Krishnasamy to discuss the evolving role of liquid biopsy and circulating tumor DNA (ctDNA) in cancer care. From biomarker-driven treatment decisions in lung cancer to emerging applications in colorectal cancer, these conversations explore how ctDNA is shaping the future of precision oncology. 📖 Read the article: cedars-sinai.org/newsroom/backt… #Oncology #LiquidBiopsy #ctDNA #CancerResearch #TumorBoard #MedOnc #ONC36

Radiopharmaceuticals are gaining momentum in modern oncology and rapidly transforming cancer care. How do you actually bring them into practice? In this episode of BackTable Tumor Board, radiation oncologists Dr. Ryan Funk and Dr. Dustin Boothe discuss modern radiopharmaceutical efficacy and tolerability, infrastructure for building a radiopharmaceutical program and its regulatory hurdles, and the future of the field—personalized dosimetry and combination therapies. This podcast is sponsored by Siemens Healthineers: na2.hubs.ly/H04cSxf0 Listen to the full discussion here: na2.hubs.ly/H04d04X0 #Oncology #Radiopharmaceuticals #RadiopharmaceuticalTherapeutics #RadiationOncology #SiemensHealthineers #ARIACOREforTheranostics #CommunityTheranostics #ONC50

Inflammatory breast cancer (IBC) rarely presents with a lump. Instead, it often appears as redness, swelling, skin thickening – often mistaken as mastitis or infection. In this episode of BackTable Tumor Board, Dr. Lindsay Peterson and Dr. Bora Lim discuss typical and atypical IBC presentations, practical diagnostic workups, evolving therapies, and how complementary tools can guide ongoing surveillance. Early recognition changes trajectories and saves lives. Listen in and share with a colleague: na2.hubs.ly/H03VZx40 #BreastCancer #IBC #Oncology #TumorBoard #ClinicalTrials #MDAnderson #49

Intermediate-risk NMIBC management is evolving - are you up to date? Our latest CME activity is now live on FreeCME, designed to support real-world decision-making across urology and oncology. This 2-hour course explores: • Risk stratification & diagnostic precision • Strategies for BCG-refractory disease • Emerging and alternative therapies • Multidisciplinary care coordination • And More Start learning today on FreeCME: na2.hubs.ly/H03QTVM0 #BladderCancer #NMIBC #Urology #Oncology #CME #MedEd

Is "treat to progression" always the right call for mHER2+ patients? Dr. Erika Hamilton & Dr. Lindsay Peterson discuss the "explosion" of HER2-directed therapies and how to balance depth of response with QoL. "It's a cool time to be in this field." Listen now: na2.hubs.ly/H03LqKB0 #OncTwitter #BreastCancer #MedicalOncology #HER2 #ONC48

Bispecific antibodies are changing NSCLC care. In this new BackTable Tumor Board episode, Drs. Kate Baker and Wade Iams review the clinical data behind the recently FDA-approved amivantamab, compare subcutaneous vs IV administration, walk through bispecific-specific toxicity recognition and management, and discuss emerging evidence on tarlatamab and where it may fit in practice. Listen now: na2.hubs.ly/H03BB1_0 #NSCLC #MetastaticLungCancer #Oncology #ClinicalTrials #TennesseeOncology #TB47

How does pulsed electric field (PEF) ablation compare to SBRT and other ablation techniques? Our latest episode features multidisciplinary perspectives on PEF's mechanism, safety, and integration with gold-standard therapies in primary and metastatic lung cancer. Listen here: na2.hubs.ly/H03r_wz0 #LungCancer #Oncology #PulsedElectricFieldAblation #Ablation #LungLesions #ClinicalTrials

Is the era of cisplatin over? The latest #BackTableTumorBoard features @AlanTanMD, Dr. Amanda Nizam, and Dr. Brad McGregor discussing the rapidly shifting MIBC landscape. Listen now: na2.hubs.ly/H03j5v90 #BladderCancer #OncTwitter #Immunotherapy #ONC45 #GUOnc

What might treatment look like beyond standard FLOT chemotherapy for GI malignancies? In Part II of our ESMO 2025 recap, Dr. Jun Gong and Dr. Jonathan Mizrahi break down what key trials like MATTERHORN and FORITTUDE-10 actually mean for day-to-day management of gastroesophageal cancers—covering efficacy signals and how (and when) these data change your practice. Listen here: na2.hubs.ly/H038s3R0 #Oncology #ESMO2025 #GastroesophagealCancers #GIOncology #ClinicalTrials #PerioperativeChemotherapy

Not all pancreatic cancer is diagnosed too late and surgery is not always first. For patients with resectable disease, preoperative treatment can meaningfully change outcomes. In the latest BackTable Tumor Board episode, Dr. Rebecca Snyder and Dr. Jonathan Mizrahi break down the role of neoadjuvant therapy, drawing on key trials and current research to guide best practices for localized pancreatic cancer. Listen here: na2.hubs.ly/H02Xb140 #PancreaticCancer #NeoadjuvantTherapy #Oncology #ClinicalTrials #MDAndersonCancerCenterHouston #OchsnerMDAndersonCancerCenterNewOrleans

How do oncologists convert vast genomic data & biomarkers into precise #LungCancer treatment plans? Watch the full NSCLC Cancer Creator Weekend episode! na2.hubs.ly/H026bkM0 #Oncology #NSCLC #CancerResearch #ONC36

As #NSCLC treatments get more complex, is a collaborative tumor board more essential than ever? We kicked off the 2025 Creator Weekend™ with a panel of top LA experts (surgery, med onc, rad onc, IP) to discuss the critical role of multidisciplinary care. Listen here: na2.hubs.ly/H020Ns-0 #LungCancer #TumorBoard #ONC34 @ReckampK @IPScottOh

The KEYNOTE-689 trial is a game-changer for head and neck cancer, but how do you actually use it in the clinic? In our new episode, a tumor board of surgeons and oncologists from @unchealth and @TJUHospital breaks down the practical side. Watch the full episode: youtube.com/watch?v=Wt-eSe… #HeadAndNeckCancer #Keynote689 #Oncology #Immunotherapy #Otolaryngology

November is Lung Cancer Awareness Month and we’re going in-depth. ⬇️ BackTable Tumor Board is bringing you a 6-part in-studio series exploring the evolving landscape of non-small cell lung cancer care. From multidisciplinary tumor board discussions to the latest in systemic, ablative, and surgical therapies - this series brings together leading experts to share insights from every angle of treatment. 🎥 The first episode premieres in early November! #LungCancerAwarenessMonth #BackTable #Oncology #CreatorWeekend

🎙️ICYMI: The BackTable Tumor Board team recently hosted a NMIBC Creator Weekend in San Diego! Over the course of the weekend, we recorded eight brand-new episodes covering the latest in NMIBC diagnosis, treatment sequencing, biomarkers, and multidisciplinary care. All 8 Episodes out now: na2.hubs.ly/H01FxN40 This content was supported by Ferring Pharmaceuticals. #TumorBoard #Urology #BladderCancer #NMIBC #MedicalEducation #ONC24

Season 3 of BackTable Tumor Board is LIVE! Our 8-episode deep dive into the complete management of Non-Muscle Invasive Bladder Cancer. This season is your guide to the latest strategies, from diagnosis to advanced therapeutics. Across the season we cover the entire spectrum of patient care. Join our incredible hosts @BogdanaSchmidt, @VigneshPackiam, and @RuchikaTalwarMD, as they lead discussions with a phenomenal group of experts. Check Out the Full Playlist: youtube.com/playlist?list=… This content was supported by Ferring Pharmaceuticals. #BladderCancer #NMIBC #MedEd #Urology #ONC24 @_backtableUro #MedicalPodcast #Oncology #CME

Playlist Now Live: youtube.com/playlist?list=…

Big news from BackTable Tumor Board 👉 We’ve got 7 brand-new episodes recorded in-studio during our NMIBC Creator Weekend, and they drop starting October 7. This series covers it all — from diagnostics and patient-centered care to sequencing therapies, biomarker data, and collaborative care approaches, plus real-world case reviews. Stay tuned - it all kicks off next week! #NMIBC #PhysicianEducation #TB @_backtableUro